Combination therapy for HCC: from CRISPR screening to the design of clinical therapies

Bibliographic Details
Main Authors: Yunguang Wang, Ling Kui, Guangchuan Wang
Format: Article
Language:English
Published: Nature Publishing Group 2021-10-01
Series:Signal Transduction and Targeted Therapy
Online Access:https://doi.org/10.1038/s41392-021-00775-1
id doaj-2c2fd5a356cb4b619b9f08adff79cc8d
record_format Article
spelling doaj-2c2fd5a356cb4b619b9f08adff79cc8d2021-10-10T11:11:21ZengNature Publishing GroupSignal Transduction and Targeted Therapy2059-36352021-10-01611210.1038/s41392-021-00775-1Combination therapy for HCC: from CRISPR screening to the design of clinical therapiesYunguang Wang0Ling Kui1Guangchuan Wang2Department of Critical Care Medicine, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of MedicineShenzhen Qianhai Shekou Free Trade Zone HospitalState Key Laboratory of Molecular Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Scienceshttps://doi.org/10.1038/s41392-021-00775-1
collection DOAJ
language English
format Article
sources DOAJ
author Yunguang Wang
Ling Kui
Guangchuan Wang
spellingShingle Yunguang Wang
Ling Kui
Guangchuan Wang
Combination therapy for HCC: from CRISPR screening to the design of clinical therapies
Signal Transduction and Targeted Therapy
author_facet Yunguang Wang
Ling Kui
Guangchuan Wang
author_sort Yunguang Wang
title Combination therapy for HCC: from CRISPR screening to the design of clinical therapies
title_short Combination therapy for HCC: from CRISPR screening to the design of clinical therapies
title_full Combination therapy for HCC: from CRISPR screening to the design of clinical therapies
title_fullStr Combination therapy for HCC: from CRISPR screening to the design of clinical therapies
title_full_unstemmed Combination therapy for HCC: from CRISPR screening to the design of clinical therapies
title_sort combination therapy for hcc: from crispr screening to the design of clinical therapies
publisher Nature Publishing Group
series Signal Transduction and Targeted Therapy
issn 2059-3635
publishDate 2021-10-01
url https://doi.org/10.1038/s41392-021-00775-1
work_keys_str_mv AT yunguangwang combinationtherapyforhccfromcrisprscreeningtothedesignofclinicaltherapies
AT lingkui combinationtherapyforhccfromcrisprscreeningtothedesignofclinicaltherapies
AT guangchuanwang combinationtherapyforhccfromcrisprscreeningtothedesignofclinicaltherapies
_version_ 1716829887645351936